000			02077 a2200577 4500
005			20250517121752.0
264		0	_c20180423
008			201804s 0 0 eng d
022			_a2045-2322
024	7		_a10.1038/srep35468 _2doi
040			_aNLM _beng _cNLM
100	1		_aChen, Minghui
245	0	0	_aApigenin potentiates TRAIL therapy of non-small cell lung cancer via upregulating DR4/DR5 expression in a p53-dependent manner. _h[electronic resource]
260			_bScientific reports _c10 2016
300			_a35468 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAnimals
650	0	4	_aApigenin _xpharmacology
650	0	4	_aApoptosis _xdrug effects
650	0	4	_aCarcinoma, Non-Small-Cell Lung _xgenetics
650	0	4	_aCaspases _xmetabolism
650	0	4	_aCell Line, Tumor
650	0	4	_aCell Proliferation _xdrug effects
650	0	4	_aDisease Models, Animal
650	0	4	_aDrug Synergism
650	0	4	_aGene Expression Regulation, Neoplastic _xdrug effects
650	0	4	_aHumans
650	0	4	_aLung Neoplasms _xgenetics
650	0	4	_aMAP Kinase Signaling System
650	0	4	_aMice
650	0	4	_aMitochondria _xdrug effects
650	0	4	_aNF-kappa B _xmetabolism
650	0	4	_aPhosphatidylinositol 3-Kinases _xmetabolism
650	0	4	_aProto-Oncogene Proteins c-akt _xmetabolism
650	0	4	_aReceptors, TNF-Related Apoptosis-Inducing Ligand _xgenetics
650	0	4	_aSignal Transduction _xdrug effects
650	0	4	_aTNF-Related Apoptosis-Inducing Ligand _xpharmacology
650	0	4	_aTumor Stem Cell Assay
650	0	4	_aTumor Suppressor Protein p53 _xmetabolism
650	0	4	_aXenograft Model Antitumor Assays
700	1		_aWang, Xueshi
700	1		_aZha, Daolong
700	1		_aCai, Fangfang
700	1		_aZhang, Wenjing
700	1		_aHe, Yan
700	1		_aHuang, Qilai
700	1		_aZhuang, Hongqin
700	1		_aHua, Zi-Chun
773	0		_tScientific reports _gvol. 6 _gp. 35468
856	4	0	_uhttps://doi.org/10.1038/srep35468 _zAvailable from publisher's website
999			_c26525160 _d26525160